Webinar: Monday, 26 September 2022, 7:00 PM

Long-acting ARV therapies

Join Medical Chronicle for a free, one-hour, CPD-accredited webinar on Long-acting ARV Therapies. This Webinar is sponsored by Janssen.

Presented by
Claire Rush

Claire Rush

  • Editor: Medical Chronicle
Dr Karlien Möller

Dr Karlien Möller

Dr Karlien Möller is a research clinician currently conducting HIV treatment studies at Ezintsha. She is currently the lead clinician on an HIV treatment switch study using long-acting rilpivirine and cabotegravir. She obtained her MBChB degree from the University of Stellenbosch in 2014.

She previously worked on HIV vaccine trials and completed her HIV diploma in 2020. Dr Möller is passionate about HIV treatment and prevention strategies as well as educating and engaging with patients to improve health outcomes.

773 professionals have already registered.


Webinar Registration

By registering for this webinar, you agree to our Terms & Conditions.

New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.

Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.

Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za